We're developing technologies to replicate cancer patients' disease ex-vivo to rapidly and accurately test a broad range of treatments simultaneously to help oncologists provide the most suitable treatment for each patient and pharmaceutical companies develop transformational therapies.
Location: Argentina, Autonomous City of Buenos Aires
Member count: 11-50
Total raised: $6.85M
Founded date: 2020
Investors 1
| Date | Name | Website |
| 30.01.2023 | Creative V... | creativeve... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 01.11.2022 | Seed | $3.3M | - | finsmes.co... |
| 31.07.2022 | Seed | $3.3M | - | - |
| 16.02.2021 | Pre-Seed | $250K | IndieBio | - |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 01.11.2022 | OncoPrecis... | OncoPrecision, a New York, NY ... | Argentina ... | - | finsmes.co... |
| 17.03.2021 | From impro... | Ultra-precise cancer therapies... | indiebio, ... | Greg Kumpa... | techcrunch... |